Voluntary Field Safety Notice Information

Philips Respironics Sleep and Respiratory Care devices

Important information for clinicians

We are fully committed to partnering with you to support your patients. 

We completed the test and research program for affected CPAP and BiPAP devices, and testing on ventilation devices continues. Please visit this page for the latest results.  

Due to the complexities of the remediation of ventilation devices, these devices will remain on a separate timeline from CPAP and BiPAP devices.

DreamStation 2

Your patients may receive a DreamStation 2 as a replacement for their affected CPAP device.

The Philips Learning connection hosts educational modules that provide overviews of the DreamStation 2 and DreamStation 2 Advanced.

Latest updates

Philips provides update on Respironics recall

October 6, 2023

Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice

September 27, 2023

The latest information for you and your practice


Our clinical bulletins have been created to help update physicians on recent developments as well as provide a status update on remediation efforts.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.